Abstract
Background: Use of cannabis and its derivative products (cannabinoids) has increased nationally as legalization for medical or recreational purposes has spread across the United States. The cannabinoid cannabidiol (CBD) has been found to increase liver transaminases. We therefore sought to better understand the impacts of cannabinoid use on outcomes after liver surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
